Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

In Michael Moeller's spirit.

Delie F, Capelle MAH.

Eur J Pharm Biopharm. 2019 Nov;144:1. doi: 10.1016/j.ejpb.2019.08.018. Epub 2019 Aug 30. No abstract available.

PMID:
31476371
2.

Use of assisted vaginal birth to reduce unnecessary caesarean sections and improve maternal and perinatal outcomes.

Nolens B, Capelle M, van Roosmalen J, Mola G, Byamugisha J, Lule J, Faye A, van den Akker T.

Lancet Glob Health. 2019 Apr;7(4):e408-e409. doi: 10.1016/S2214-109X(19)30043-9. No abstract available.

3.

Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine.

Capelle MAH, Babich L, van Deventer-Troost JPE, Salerno D, Krijgsman K, Dirmeier U, Raaby B, Adriaansen J.

Eur J Pharm Biopharm. 2018 Aug;129:215-221. doi: 10.1016/j.ejpb.2018.06.001. Epub 2018 Jun 2.

PMID:
29870747
4.

Antenatal prognostic factor of fetal echogenic bowel.

Ronin C, Mace P, Stenard F, Loundou A, Capelle M, Mortier I, Pellissier MC, Sigaudy S, Levy A, D'ercole C, Hoffmann P, Merrot T, Lopater J, De Lagausie P, Philip N, Bretelle F.

Eur J Obstet Gynecol Reprod Biol. 2017 May;212:166-170. doi: 10.1016/j.ejogrb.2017.01.060. Epub 2017 Mar 3.

PMID:
28391132
5.

[Segmental approach to congenital heart diseases: Principles and applications to prenatal imaging].

Lesieur E, Dabadie A, Pico H, Bourachot M, Gach P, Sorensen C, Capelle M, Bretelle F, Sigaudy S, Gorincour G.

Gynecol Obstet Fertil. 2016 Jul-Aug;44(7-8):428-34. doi: 10.1016/j.gyobfe.2016.06.003. Epub 2016 Jul 19. French.

PMID:
27451065
6.

Prenatal diagnosis of bowel malposition using T2-weighted fetal MRI sequences.

Kheiri M, Lesieur E, Dabadie A, Colombani M, Capelle M, Sigaudy S, Guidicelli B, Heckenroth H, Delagausie P, Pico H, Philip N, Bretelle F, Gorincour G.

Diagn Interv Imaging. 2016 Sep;97(9):857-61. doi: 10.1016/j.diii.2016.01.010. Epub 2016 Mar 15.

7.

Facing the next frontier of fetal magnetic resonance imaging.

Lesieur E, Dabadie A, Pico H, Capelle M, Bretelle F, Gorincour G.

Ultrasound Obstet Gynecol. 2016 Jul;48(1):125-6. doi: 10.1002/uog.15794. Epub 2016 Jun 1. No abstract available.

8.

Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial.

Boulvain M, Senat MV, Perrotin F, Winer N, Beucher G, Subtil D, Bretelle F, Azria E, Hejaiej D, Vendittelli F, Capelle M, Langer B, Matis R, Connan L, Gillard P, Kirkpatrick C, Ceysens G, Faron G, Irion O, Rozenberg P; Groupe de Recherche en Obstétrique et Gynécologie (GROG).

Lancet. 2015 Jun 27;385(9987):2600-5. doi: 10.1016/S0140-6736(14)61904-8. Epub 2015 Apr 8.

PMID:
25863654
9.

Picometer-scale surface roughness measurements inside hollow glass fibres.

Brun C, Buet X, Bresson B, Capelle MS, Ciccotti M, Ghomari A, Lecomte P, Roger JP, Petrovich MN, Poletti F, Richardson DJ, Vandembroucq D, Tessier G.

Opt Express. 2014 Dec 1;22(24):29554-67. doi: 10.1364/OE.22.029554.

PMID:
25606888
10.

17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.

Winer N, Bretelle F, Senat MV, Bohec C, Deruelle P, Perrotin F, Connan L, Vayssière C, Langer B, Capelle M, Azimi S, Porcher R, Rozenberg P; Groupe de Recherche en Obstétrique et Gynécologie.

Am J Obstet Gynecol. 2015 Apr;212(4):485.e1-485.e10. doi: 10.1016/j.ajog.2014.10.1097. Epub 2014 Oct 30.

PMID:
25448515
11.

Contribution of the foetal uro-MRI in the prenatal diagnosis of uronephropathies.

Pico H, Dabadie A, Bourliere-Najean B, Philip N, Capelle M, Aschero A, Quarello E, Guys JM, Hery G, Petit P, Gorincour G.

Diagn Interv Imaging. 2014 Jun;95(6):573-8. doi: 10.1016/j.diii.2014.02.011. Epub 2014 Mar 15.

12.

[Pronostic risk assessment of delivery, in patients admitted for threatened preterm birth, in a tertiary care maternity center].

Berthelot-Ricou A, Tur S, Guidicelli B, Capelle M, Gamerre M, Courbiere B.

J Gynecol Obstet Biol Reprod (Paris). 2014 Oct;43(8):600-9. doi: 10.1016/j.jgyn.2013.09.002. Epub 2013 Dec 15. French.

13.

Influence of methionine oxidation on the aggregation of recombinant human growth hormone.

Mulinacci F, Poirier E, Capelle MA, Gurny R, Arvinte T.

Eur J Pharm Biopharm. 2013 Sep;85(1):42-52. doi: 10.1016/j.ejpb.2013.03.015.

PMID:
23958317
14.

Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish.

Christen V, Capelle M, Fent K.

Toxicol Appl Pharmacol. 2013 Oct 15;272(2):519-28. doi: 10.1016/j.taap.2013.06.011. Epub 2013 Jun 22.

PMID:
23800688
15.

[Cervical ripening at term with repeated administration of dinoprostone vaginal pessary].

Petrovic Barbitch M, Gnisci A, Marcelli M, Capelle M, Guidicelli B, Cravello L, Gamerre M, Agostini A.

Gynecol Obstet Fertil. 2013 Jun;41(6):346-50. doi: 10.1016/j.gyobfe.2013.02.008. Epub 2013 Apr 4. French.

PMID:
23562543
16.

Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial.

Senat MV, Porcher R, Winer N, Vayssière C, Deruelle P, Capelle M, Bretelle F, Perrotin F, Laurent Y, Connan L, Langer B, Mantel A, Azimi S, Rozenberg P; Groupe de Recherche en Obstétrique et Gynécologie.

Am J Obstet Gynecol. 2013 Mar;208(3):194.e1-8. doi: 10.1016/j.ajog.2013.01.032.

PMID:
23433324
17.

Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab).

Peters BJ, Capelle MA, Arvinte T, van de Garde EM.

MAbs. 2013 Jan-Feb;5(1):162-70. doi: 10.4161/mabs.22873. Epub 2012 Dec 19.

18.

[Management of preterm and prelabour rupture of membranes in France].

Couteau C, Haumonté JB, Bretelle F, Capelle M, D'Ercole C.

J Gynecol Obstet Biol Reprod (Paris). 2013 Feb;42(1):21-8. doi: 10.1016/j.jgyn.2012.10.008. Epub 2012 Nov 24. French.

19.

RF performances of inductors integrated on localized p+-type porous silicon regions.

Capelle M, Billoué J, Poveda P, Gautier G.

Nanoscale Res Lett. 2012 Sep 25;7(1):523. doi: 10.1186/1556-276X-7-523.

20.

Room light anodic etching of highly doped n-type 4 H-SiC in high-concentration HF electrolytes: Difference between C and Si crystalline faces.

Gautier G, Cayrel F, Capelle M, Billoué J, Song X, Michaud JF.

Nanoscale Res Lett. 2012 Jul 3;7(1):367. doi: 10.1186/1556-276X-7-367.

21.

Evaluation of mesoporous silicon thermal conductivity by electrothermal finite element simulation.

Siegert L, Capelle M, Roqueta F, Lysenko V, Gautier G.

Nanoscale Res Lett. 2012 Jul 31;7(1):427. doi: 10.1186/1556-276X-7-427.

22.

Plasma-deposited fluoropolymer film mask for local porous silicon formation.

Defforge T, Capelle M, Tran-Van F, Gautier G.

Nanoscale Res Lett. 2012 Jun 26;7(1):344. doi: 10.1186/1556-276X-7-344.

23.

Prenatal diagnosis of atypical adrenal neuroblastoma with pulmonary metastases is possible: Impact on the assessment of prenatal prognosis.

Menager N, Quarello E, Capelle M, Lacroze V, Coze C, De Lagausie P, Gorincour G.

Diagn Interv Imaging. 2012 Jul;93(7-8):632-4. doi: 10.1016/j.diii.2012.03.005. Epub 2012 Apr 5. No abstract available.

24.

Noncovalent PEGylation: different effects of dansyl-, L-tryptophan-, phenylbutylamino-, benzyl- and cholesteryl-PEGs on the aggregation of salmon calcitonin and lysozyme.

Mueller C, Capelle MA, Seyrek E, Martel S, Carrupt PA, Arvinte T, Borchard G.

J Pharm Sci. 2012 Jun;101(6):1995-2008. doi: 10.1002/jps.23110. Epub 2012 Mar 23.

PMID:
22447529
25.

Ultraviolet Resonance Raman spectroscopy used to study formulations of salmon calcitonin, a starch-peptide conjugate and TGF-β3.

Patois E, Larmour IA, Bell SE, Palais C, Capelle MA, Gurny R, Arvinte T.

Eur J Pharm Biopharm. 2012 Jun;81(2):392-8. doi: 10.1016/j.ejpb.2012.02.016. Epub 2012 Mar 6.

PMID:
22421544
26.

[The right to withdraw].

Capelle MP.

Rev Infirm. 2012 Feb;(178):31-2. French.

PMID:
22400398
27.

Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.

Rozenberg P, Chauveaud A, Deruelle P, Capelle M, Winer N, Desbrière R, Perrotin F, Bohec C, Connan L, Vayssière C, Langer B, Mantel A, Azimi S, Porcher R, Azria E; Groupe De Recherche En Obstétrique et Gynécologie.

Am J Obstet Gynecol. 2012 Mar;206(3):206.e1-9. doi: 10.1016/j.ajog.2011.12.026. Epub 2011 Dec 27.

PMID:
22381603
28.

Does the experience of the provider affect pregnancy rates after embryo transfer?

Desparoir A, Capelle M, Banet J, Noizet A, Gamerre M, Courbière B.

J Reprod Med. 2011 Sep-Oct;56(9-10):437-43.

PMID:
22010530
29.

Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.

Patois E, Capelle MA, Gurny R, Arvinte T.

Vaccine. 2011 Oct 6;29(43):7404-13. doi: 10.1016/j.vaccine.2011.07.067. Epub 2011 Jul 29.

PMID:
21803109
30.

Tryptophan-mPEGs: novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylation.

Mueller C, Capelle MA, Arvinte T, Seyrek E, Borchard G.

Eur J Pharm Biopharm. 2011 Nov;79(3):646-57. doi: 10.1016/j.ejpb.2011.06.003. Epub 2011 Jun 14.

PMID:
21703347
31.

Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitonin.

Mueller C, Capelle MA, Arvinte T, Seyrek E, Borchard G.

J Pharm Sci. 2011 May;100(5):1648-62. doi: 10.1002/jps.22401. Epub 2010 Nov 24.

PMID:
21374604
32.

Enhanced physical stability of human calcitonin after methionine oxidation.

Mulinacci F, Poirier E, Capelle MA, Gurny R, Arvinte T.

Eur J Pharm Biopharm. 2011 Jun;78(2):229-38. doi: 10.1016/j.ejpb.2010.12.038. Epub 2011 Feb 4.

PMID:
21296150
33.

Stability of human growth hormone: influence of methionine oxidation on thermal folding.

Mulinacci F, Capelle MA, Gurny R, Drake AF, Arvinte T.

J Pharm Sci. 2011 Feb;100(2):451-63.

PMID:
21249719
34.

Oxidized recombinant human growth hormone that maintains conformational integrity.

Mulinacci F, Bell SE, Capelle MA, Gurny R, Arvinte T.

J Pharm Sci. 2011 Jan;100(1):110-22. doi: 10.1002/jps.22268. Epub 2010 Jun 23.

PMID:
20575051
35.

Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2).

Luca L, Capelle MA, Machaidze G, Arvinte T, Jordan O, Gurny R.

Int J Pharm. 2010 May 31;391(1-2):48-54. doi: 10.1016/j.ijpharm.2010.02.015. Epub 2010 Feb 13.

PMID:
20156542
36.

High-throughput formulation screening of therapeutic proteins.

Capelle MA, Arvinte T.

Drug Discov Today Technol. 2008 Autumn;5(2-3):e71-9. doi: 10.1016/j.ddtec.2009.03.003.

PMID:
24981094
37.

A high throughput protein formulation platform: case study of salmon calcitonin.

Capelle MA, Gurny R, Arvinte T.

Pharm Res. 2009 Jan;26(1):118-28. doi: 10.1007/s11095-008-9662-8. Epub 2008 Jul 4.

PMID:
18600433
38.

Comparison of ropivacaine and lidocaine for paracervical block during surgical abortion.

Agostini A, Provansal M, Collette E, Capelle M, Estrade JP, Cravello L, Gamerre M.

Contraception. 2008 May;77(5):382-5. doi: 10.1016/j.contraception.2008.01.009. Epub 2008 Mar 21.

PMID:
18402857
39.

Preeclampsia: impaired inflammatory response mediated by Toll-like receptors.

Mazouni C, Capo C, Ledu R, Honstettre A, Agostini A, Capelle M, Mege JL, Bretelle F.

J Reprod Immunol. 2008 Jun;78(1):80-3. Epub 2007 Nov 26.

PMID:
18023484
40.

High throughput methods to characterize protein permeation and release.

Capelle MA, Gurny R, Arvinte T.

Int J Pharm. 2008 Feb 28;350(1-2):272-8. Epub 2007 Sep 14.

PMID:
17997238
41.

Results of endovascular treatment in cases of abnormal placentation with post-partum hemorrhage.

La Folie T, Vidal V, Mehanna M, Capelle M, Jaquier A, Moulin G, Bartoli JM.

J Obstet Gynaecol Res. 2007 Oct;33(5):624-30.

PMID:
17845319
42.

Transvaginal ultrasound measurement of cervical length and efficacy of misoprostol in first-trimester pregnancy failure.

Agostini A, Capelle M, Ronda I, Bretelle F, Cravello L, Blanc B.

Ultrasound Obstet Gynecol. 2007 Jun;29(6):671-3.

43.

Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy.

Agostini A, Blanc K, Ronda I, Romain F, Capelle M, Blanc B.

Fertil Steril. 2007 Aug;88(2):504-6. Epub 2007 Apr 6.

PMID:
17418833
44.

[The worrying rise in the frequency of cesarean section].

Blanc B, Capelle M, Bretelle F, Leclaire M, Bouvenot J.

Bull Acad Natl Med. 2006 Apr-May;190(4-5):905-13; discussion 914. French.

PMID:
17195615
45.

High throughput screening of protein formulation stability: practical considerations.

Capelle MA, Gurny R, Arvinte T.

Eur J Pharm Biopharm. 2007 Feb;65(2):131-48. Epub 2006 Sep 29.

PMID:
17107777
46.

In situ methotrexate injection for treatment of recurrent endometriotic cysts.

Agostini A, De Lapparent T, Collette E, Capelle M, Cravello L, Blanc B.

Eur J Obstet Gynecol Reprod Biol. 2007 Jan;130(1):129-31. Epub 2006 Mar 10.

PMID:
16530317
47.

[Cervical ripening using misoprostol before hysteroscopy].

Agostini A, Blanc K, Ronda I, Capelle M, Cravello L, Blanc B.

Gynecol Obstet Fertil. 2006 Jan;34(1):49-53. Epub 2006 Jan 18. Review. French.

PMID:
16413811
48.

Influence of clinical and ultrasound factors on the efficacy of misoprostol in first trimester pregnancy failure.

Agostini A, Ronda I, Capelle M, Romain F, Bretelle F, Blanc B.

Fertil Steril. 2005 Oct;84(4):1030-2.

PMID:
16213867
49.

Laparoscopic removal of a remaining myoma after vaginal hysterectomy: a case report.

Agostini A, Vejux N, Capelle M, Ronda I, Blanc B.

J Minim Invasive Gynecol. 2005 Jul-Aug;12(4):372-3.

PMID:
16036202
50.

Supplemental Content

Loading ...
Support Center